We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Vaccination is a "marvel of scientific endeavour" that brings benefits to the masses. But a laissez-faire attitude to funding may hamper vaccine research and development.

In this article, G. J. V. Nossal says that the global funding climate for vaccine researching has improved over the past few years. He illustrates his point with examples of national and international efforts that he says provide a healthier climate for vaccine research and development.

Nossal also reminds his readers that funding research is not the 'be all and end all' of vaccine development. Rather, it is equally important to make sure a vaccine is properly introduced in developing nations once it has been approved for distribution.

Reference: Nature Immunology 5, 457 (2004)

Link to the full Nature Immunology article

Related topics